NowYon Medical Scores ￥100M in Series A and A+ Round of Financing

(VCBeat) May. 14, 2021 -- NowYon Medical announced that it has recently brought in ￥100M in Series A and A+ financing. The Series A round was led by Dalton Venture, with participation from Fengshuo Venture Capital and the existing investors including China Growth Capital and Rays Venture Capital. The extended A round was led by Yijing Capital. The existing investor Dalton Venture also participated in the Series A+ round, with China Renaissance acting as the exclusive financial adviser. 

After this round of financing, NowYon Medical will advance its core neurointerventional products to the clinical stage, as well as develop its product pipeline in other fields.

Founded in 2019, NowYon Medical focuses on the field of neurointerventional therapy, with a product pipeline for neurointerventional bleeding, ischemia, and so on, including blood flow guidance system, stents, catheters, balloon catheters, microcatheters, etc. Among them, the core product -- blood flow guidance system has a full coverage of indications for small to large aneurysms, and the core indicators of the product are all on the top of the world. Another core product of stent retriever thrombectomy and spiration thrombectomy is the first in the world to reduce intraoperative risk while ensuring the adequacy of thrombectomy.

Dalton Venture is focused on early-stage investment and mergers and acquisitions in the healthcare industry, with a focus on medical services and innovative medical technologies. The core team of Dalton Venture is from the medical and healthcare industry, with rich experience in enterprise operation management, investment and mergers and acquisitions.

CGC is a China-focused seed and early venture investor since 2006. They back extraordinary entrepreneurs from seed to early growth in enterprise, frontier tech, life science, marketplace and consumer verticals.They pioneered fintech and enterprise innovations in China since founding in 2006 with a unique portfolio of fintech, enterprise software, frontier technology and marketplace players.